Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
Ah-Rong Nam, Ji-Won Kim, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Do-Youn Oh, Yung-Jue Bang
Cancer Res Treat. 2019;51(3):886-900. Published online 2018 Oct 1 DOI: https://doi.org/10.4143/crt.2018.375
Citations to this article as recorded by 
COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma
Jiahui Liu, Dexing Han, Junfeng Xuan, Jinye Xie, Weijia Wang, Quan Zhou, Kang Chen
Aging.2024; 16(6): 5264. CrossRef
Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer
Liping Wang, Xiaojiao Zeng, Gui Yang, Guohong Liu, Yunbao Pan
Heliyon.2022; 8(12): e12553. CrossRef
Jab1/Cops5: a promising target for cancer diagnosis and therapy
Chunjue Yuan, Dong Wang, Guohong Liu, Yunbao Pan
International Journal of Clinical Oncology.2021; 26(7): 1159. CrossRef